🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Yesterday was one of those unforgettable moments. Watching Tim Andrews throw out the first pitch at Fenway Park was pretty incredible and a powerful reminder of why we do this work. ⚾ Thank you to our partners at MGH. #Transplantation #Fenway #MGH wcvb.com/article/man-wh…

A man with a severe speech disability is able to speak expressively and sing using a brain implant that translates his neural activity into words almost instantly. go.nature.com/405JUcW

China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. IQVIA iqvia.com/library/videos…

1/🚨WOW! Intellia Therapeutics presented new data from a 3-year follow-up which showed that a single dose of lonvo-z - $NTLA-2002, led to a 98% (!) reduction in monthly HAE attack rate & all 10 patients were attack-free for a median of 23 months through the latest follow-up. #EHA2025 $XBI

Uber just added a B-2 pickup to their Middle East UberHeli service. Should be popular.

Congrats to Verve (ARCH co-seed) for finding a good partner (Lilly) and thinking big in gene editing for common diseases. The future.

$LYEL - Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma - stocktitan.net/news/LYEL/lyel…

Today, I’m proud to introduce a revolutionary pathway to drug approvals that will significantly accelerate the delivery of crucial treatments to the American public. I'm committed to fostering innovation that saves lives. The National Priority Voucher program brings the agility

This is a great idea.

Lyell far ahead of JNJ and Kite CD19/20, many more patients, treating an apparently much sicker group, showing longer durability, looks like favorable tox. The days of CD19 alone are over. CD19/20 wins, and JNJ, KITE are behind. (ARCH was the first venture backer of Carl June

Ultimately when you see data like Lyell today, it gives you hope that these cancers can actually be cured, and the patients that recur, or fall through the cracks, can be treated. The biggest problem with our medical system today it we save these great new innovations for

🚀 Xaira Therapeutics has just dropped a game-changer for AI-driven biology. Today, we unveiled X-Atlas/Orion, the largest publicly available genome-wide Perturb-seq dataset to date—spanning 8.4 million single cells with perturbations across all ~20,000 human protein-coding

NEW: After spending its first year in relative quiet since its billion-dollar public debut, Xaira is out with its first preprint I talked with Xaira's lead scientist on the project, which includes releasing 8 million cells' worth of Perturb-seq: endpoints.news/ai-biotech-xai…

𝙺𝚒𝚖𝚋𝚊𝚕 𝙼𝚞𝚜𝚔 🤠 They don’t understand.

How the GBU-57A bomb works [🎞️ AiTelly]

New report from ProPublica shows that 47 Chicago schools are operating at less then 1/3 capacity. About 150 schools are half empty. One school has 28 students enrolled at a cost of $93k a student. Chicago schools are failing and not a single student can read at grade level in

Solar power in China will exceed ALL sources of electricity combined in the USA in 3 to 4 years. Wake up call.

Pitchbook data on biotech fund raises by year via BioSpace. No wonder we've felt the pain of coming off 2018-2019 but it's looking quite anaemic now.